News for Artisan Acquisition Corp. (ARTAU)

Prenetics Announces Fourth Quarter and Full Year 2023 Financial Results

Read the rationale behind our selection of 2022 Achievement Award winners: House Awards - Asia.

LONDON and HONG KONG, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a global leader in genomic...

Revenue of US$51.7 million in the second quarter of 2022Loss from operations of US$ million and adjusted EBITDA1 of US$6.5 million in the same periodRaises full year adjusted EBITDA guidance to the... | September 9, 2022

GuruFocus Article or News written by insider and the topic is about:

By Marc H. Iyeki, Senior Consultant Global Markets Advisory Group LLC.     The US capital market is the deepest and most prestigious in the world, attracting companies that aspire to distinguish themselves from their local peers and stand among the world’s best. Only a select group of companies can meet the challenge of being a US-listed public company. Members of this group gain access to benefits that are largely unavailable to companies that stay within the comfort zones of their local markets.

Last year was a banner year for special-purpose acquisition companies, but so far it’s unclear if this year will pan out to be nearly as active for the SPAC market.

Prenetics becomes the first Hong Kong unicorn to list on Nasdaq and its shares began trading on May 18 under ticker

HONG KONG — Hong Kong-based COVID-19 testing firm Prenetics Ltd’s shares fell 4.4% to $7.45 in their Nasdaq debut on Wednesday, following its merger with a…

DUBAI (BLOOMBERG) - Asian sponsors of blank-cheque firms are facing a tough market for initial public offerings (IPOs) wherever they turn, as a combination of increasing regulatory scrutiny and fading investor demand shutters the window for new listings from the US to Asia. . Read more at straitstimes.com.

/PRNewswire/ -- Prenetics Group Limited ("Prenetics" or the "Company"), a global leader in genomic and diagnostic testing, today announced its financial...

Revenue reached US$136.5 million, up 1,039% year-over-year Adjusted EBITDA was US$31.5 million, increased by US$34.6 million year-over-year Prenet...

Adrian Cheng’s blank-check company Artisan Acquisition Corp. will merge with Prenetics in a deal that would value the biotech firm at $1.25 billion.